Skip to main content
SpringerLink
Log in

Drug resistance in human pathogenic fungi

  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

Abstract

Since the therapy of the mycoses, particularly the systemic mycoses, is relatively long-term in nature, emergence of resistance to antifungal drugs during the treatment of period would be of considerable clinical importance. However, most reports of resistance to antifungal agents among human pathogenic fungi indicate that naturally-occurring resistance is very rare, and that the induction of resistant mutants or variants is much more difficult to achieve in vitro and in vivo than with bacteria. As a matter of fact, amphotericin B and some other classic antifungals have not as yet posed a broadly significant problem relative to drug resistance despite their widespread and frequent use. Fungal resistance has thus received little attention, in contrast to the critical importance of bacterial resistance frequently caused by a variety of antibacterial chemotherapeutic agents, until a single exception to this generalization arose with the advent of flucytosine. This new development has aroused great interest in the problem of fungal resistance among the scientists involved with medical mycology. It is generally believed that fungi, like bacteria, are intrinsically capable of developing resistance to antifungal agents. As illustrated by flucytosine, inherently resistant mutants to antifungals occur within sensitive strains of human pathogenic fungi with significant frequency. Given the relatively high degree of such primary resistance, these mutants should develop secondary resistance during therapy, thus resulting in considerable limitations in the clinical usefulness of the antifungals. Virtually, all unsuccessful cases of mycoses treated with some of the recently exploited antifungal drugs, albeit scarce to date, would obviously be attributable to the occurrence of secondary resistance. The exploitation of new antifungal drugs thus requires investigations of their resistance as one of the most important research projects to be undertaken before receiving approval for use on humans. This paper reviews from various aspects the literature on resistance to various classic and novel antifungal agents among human pathogenic fungi. The resistance of some nonpathogenic fungi to these agents will also be described from genetic and biochemical points of view.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. ArroyoJ., MedoffG. and KobayashiG.S. (1977): Therapy of murine aspergillosis with amphotericin B in combination with rifampin or 5-fluorocytosine -Antimicrob. Agents Chemother. 11: 21–25.

    Google Scholar 

  2. ArtisW.M., BonnieM., OdleB.M. and JonesH.E. (1981): Griseofulvin-resistant dermatophytosis correlates with in vitro resistance - Arch. Dermatol. 117: 16–19.

    Google Scholar 

  3. AtharM.A. (1969): A study of the effects of some polyene antibiotics on Candida sp. - Ph.D. Thesis -University of London - England.

    Google Scholar 

  4. AtharM.A. and WinnerH.I. (1971): The development of resistance by Candida species to polyene antibiotics in vitro - J. Med. Microbiol. 4: 505–517.

    Google Scholar 

  5. AtkinsonG.W. and IsraelH.J. (1973): 5-Fluorocytosine treatment of meningeal and pulmonary aspergillosis - Am. J. Med. 55: 496–504.

    Google Scholar 

  6. AugerP., DumasC. and JolyJ. (1979): A study of 666 strains of Candida albicans: correlation between serotype and susceptibility to 5-fluorocytosine - J. Infect. Dis. 139: 590–594.

    Google Scholar 

  7. AytounR.S.C., CampbellA.H., NapierE.J. and SeilerD.A.L. (1960): Mycological aspects of the action of griseofulvin against dermatophytes - Arch. Dermatol. 81: 650–656.

    Google Scholar 

  8. BaierR. and PuppelH. (1978): Antimykotika-Empfindlichkeit von Hefen aus klinischem Untersuchungsmaterial im Blättchendiffusiontest -Dt. med. Wschr. 103: 1112–1116.

    Google Scholar 

  9. BeggsW.M., AndrewF.A. and SarosiG.A. (1977): Evidence for sequential action of amphotericin B and 5-fluorocytosine on Candida albicans ATCC 11 651 -Res. Commun. Chem. Pathol. and Pharmacol. 16: 575–580.

    Google Scholar 

  10. BeggsW.H., SarosiG.A. and AndrewsF.A. (1974): Synergistic action of amphotericin B and rifampin on Candida albicans - Am. Rev. Resp. Dis. 110: 671–673.

    Google Scholar 

  11. BeggsW.H., SarosiG.A. and SteelN.M. (1976): Inhibition of potentially pathogenic yeastlike fungi by clotrimazole in combination with 5-fluorocytosine or amphotericin B - Antimicrob. Agents Chemother. 9: 863–865.

    Google Scholar 

  12. BeggsW.M., SarosiG.A. and WalkerM.I. (1976): Synergistic action of arnphotericin B and rifampin against Candida species - J. Infect. Dis. 133: 206–209.

    Google Scholar 

  13. BennetJ.E. (1977): Drugs 5 years later: Flucytosine -Ann. Intern. Med. 86: 319–322.

    Google Scholar 

  14. BennetJ.E., PlempelM., StevensD.A. and ScholerH.J. (1978): Chemotherapy of fungal diseases - In: Siegenthaler W. and Luthy R. eds. Current Chemotherapy, Proc. 10th International Congress of Chemotherapy, Zurich, 1977, Vol. 1, American Society for Microbiology, Washington, D.C., pp. 53–55.

    Google Scholar 

  15. BergyM.E. and EbleT.E. (1968): The filipin complex -Biochemistry 7: 653–658.

    Google Scholar 

  16. BernhardtH. and KnokeM. (1976): Resistenzprobleme bei Schleimhaut- und Organmykosen -Ber. Ges. innere Med. 10: 252–254.

    Google Scholar 

  17. BlockE.R. and BennetJ.E. (1973): The combined effect of 5-fluorocytosine and arnphotericin B in the therapy of murine cryptococcosis - Proc. Soc. Exp. Biol. Med. 142: 476–480.

    Google Scholar 

  18. BlockE.R. and BennetJ.E. (1974): 5-Fluorocytosine resistance in Candida albicans infections in man -Am. Rev. Resp. Dis. 109: 723–724.

    Google Scholar 

  19. BlockE.R., JenningsA.E. and BennetJ.E. (1973): 5-Fluorocytosine resistance in Cryptococcus neoformans- Antimicrob. Agents Chemother. 3: 649–656.

    Google Scholar 

  20. BodenhoffJ. (1968a): Resistance studies of Candida albicans, with special reference to two patients subjected to prolonged treatment - Odont. Tidskr. 76: 279–294.

    Google Scholar 

  21. BodenhoffJ. (1968b): Development of strains of Cryptococcus neoformans resistant to nystatin, amphotericin B, trichomycin and polymyxin B - Acta Path. Microbiol. Scand. 73: 572–582.

    Google Scholar 

  22. BodenhoffJ. (1969): Development of strains of genus Candida and genus Torulopsis resistant to antimycotics - Acta Path. Microbiol. Scand. 75: 622–630.

    Google Scholar 

  23. BondruI. (1969): De la resistance des Candida albicans à la nystatine - J. Pharm. belg. 24: 162–185.

    Google Scholar 

  24. BorgersM. (1987): Changes in fungal ultrastructure after Raconazole treatment - In: Vanden Bossche H., Mackenzie D.W.R. and Cauwenbergh eds. Aspergillus and Aspergillosis - Plenum - New York -pp. 193–206.

    Google Scholar 

  25. BorgersM. and Van deVenM.-A. (1987): Degenerative changes in fungi after itraconazole treatment - Rev. Infect. Dis. 9 Suppl. 1: S33-S42.

    Google Scholar 

  26. BrinkmannF. (1981): Sekundäre Sensibilitätsänderung von Candida albicans gegen 5-Fluoro-cytosin (5-FC) in vitro: Vergleich von fünf Methoden im Hinblick auf Routineuntersuchungen - Z. Hautkr. 56: 1255–1263.

    Google Scholar 

  27. CapekA. and SimekA. (1972): Antimicrobial agents. 115. Content of ergosterol and the problem of transient resistance of dermatophytes - Folia microbiol. 17: 239–240.

    Google Scholar 

  28. CapekA., SimekA., LeinerJ. and WeichetJ. (1970): Antimicrobial agents. 6. Antimycotic activity and problems of reistance - Folia microbiol. 15: 314–317

    Google Scholar 

  29. CartwrightR.Y., ShaldonC. and HallG.H. (1972): Urinary candidiasis after renal transplantation - Br. Med. J. 2: 351.

    Google Scholar 

  30. CorradoM.L., WeitzmanI., StanekA., GoetzR. and AgyareE. (1980): Subcutaneous infection with Phialophora richardsiae and its susceptibility to 5-fluorocytosine, arnphotericin B and miconazole- Sabouraudia 18: 97–104.

    Google Scholar 

  31. CrouzetM., PerrotM., NogueiraM. and BegueretJ. (1978): Genetic and biochemical analysis of cycloheximide resistance in the fungus Podospora anserina - Biochem. Genet. 16: 271–286.

    Google Scholar 

  32. DaviesR.R., EverallJ.D. and HamiltonE. (1967): Mycological and clinical evaluation of griseofulvin for chronic onychomycosis - Br. Med. J. iii: 464–468.

    Google Scholar 

  33. DaviesR.R. and SavageM.A. (1974): Observations on 5-fluorocytosine and Candida albicans - Sabouraudia 12: 302–308.

    Google Scholar 

  34. DefeverK.S., WhelanW.L., RogersA.L., BenekeE.S., VeselenakJ.M. and SoilD.R. (1982): Candida albicans resistance to 5-fluorocytosine: frequency of partially resistant strains among clinical isolates - Antimicrob. Agents Chemother. 22: 810–815.

    Google Scholar 

  35. DekkerJ. (1985): The development of resistance to fungicides. In: Hutson D.H. and Roberts T.R. eds., Progress in Pesticide Biochemistry and Toxicology -John Wiley & Sons - New York - N.Y. - Vol. 4: 165–218.

    Google Scholar 

  36. DermoumiH. (1982): Antimykotika - Empfindlichkeit bei klinisch bedeutsamen Helfen und Schimmelpilzen im Hemmholftert - Mykosen 25: 109–117.

    Google Scholar 

  37. DiasioR.B., BennettJ.E. and MyersC.E. (1978): The mode of action of 5-fluorocytosine - Biochem. Pharmac. 27: 703–707.

    Google Scholar 

  38. DonovikR., PansyF.E., StoutH.A., StanderH., WeinsteinM.J. and GoldW. (1955): Some in vitro characteristics of nystatin (mycostatin) - In: Sternberg T.H. and Newcomer V.D. eds. International Symposium on therapy of Fungus Diseases, Little, Brown & Co. - Boston - pp. 875–883.

    Google Scholar 

  39. Drouhet E. (1973): Chemotherapy of systemic and deep mycoses due to opportunistic fungi. In: Daikos, G.K. ed. - Progress in Chemotherapy — Proc. 8th Int. Congr. Chemother. - Athens - Vol. 1, pp. 875–883.

  40. DrouhetE., Ktenidou-KartalisS. and ImprovisiL. (1976a): Phenotypes de resistance a la 5-fluorocytosine chez Cryptococcus neoformans - Bull. Soc. fr. Mycol. med. 5: 17–20.

    Google Scholar 

  41. DrouhetE., Ktenidou-KartalisS. and ImprovisiL. (1976b): Phénotypes de résistance aux 5-fluoropyrimidines chez les Torulopsis - Bull. Soc. fr. Mycol. méd. 5: 91–94.

    Google Scholar 

  42. DrouhetE., Mercier-SoucyL. and MontplaisirS. (1975): Sensibilité et résistance des levures pathogéenes aux 5-fluoropyrimidines. 1. Relation entre les phénotypes de résistance à la 5-fluorocytosine, le sérotype de Candida albicans et Pécologie de différentes espèces de Candida d'origine humaine - Ann. Microbiol. (Inst. Past.) 126B: 25–29.

    Google Scholar 

  43. DrutzD.J. and LehrerR.I. (1978): Development of amphotericin B-resistant Candida tropicalis in a patient with defective leukocyte function - Am. J. Med. Sci. 276: 77–92.

    Google Scholar 

  44. FasoliM.O.F., KerridgeD. and RyleyJ.F. (1990): Pathogenicity of 5-fluorocytosine resistant strains of Candida albicans - J. Med. Vet. Mycol. 28: 27–34.

    Google Scholar 

  45. FassR.J. and PerkinsR.L. (1974): 5-Fluorocytosine in the treatment of cryptococcal and Candida mycoses -Ann. Intern. Med. 74: 535–539.

    Google Scholar 

  46. FeiginR.D., ShacklefordP.G., EisenS., SpitlerL.E., PickeringL.K. and AndersonP.C. (1974): Treatment of mucocutaneous candidiasis with transfer factor -Pediatrics 53: 63–70.

    Google Scholar 

  47. Fields B.T., Meredith W.R., Galbraith J.E. and Hardin H.F. (1974): Studies with amphotericin B and 5-fluorocytosine in aspergillosis — Clin. Res. 22: 32A.

  48. FirkinF.C. (1974): Therapy of deep-seated fungal infections with 5-fluorocytosine - Aust. N.Z. J. Med. 4: 462–467.

    Google Scholar 

  49. FisherB.K., SmithJ.G., CrounseR.G., RuthF.J.Jr. and BlankH. (1961): Verrucous epidermophytosis: its response and resistance to griseofulvin - Arch. Dermatol. 84: 375–380.

    Google Scholar 

  50. FlandroisJ.P. (1975): Etat actuel de la sensibilité a la fluoro-5-cytosine des levures du genre Candida isolées chez l'homme - Med. Mal. infect. 5: 351–356.

    Google Scholar 

  51. FordJ.H. and KlomparensW. (1960): Cycloheximide (Acti-dione) and its non-agricultural uses - Antibiot. Chemother. 10: 682–687.

    Google Scholar 

  52. FrybergM., OehIschlagerA.C. and UnrauA.M. (1974): Sterol biosynthesis in antibiotic-resistant yeast: nystatin - Arch. Biochem. Biophys. 160: 83–89.

    Google Scholar 

  53. FrybergM., OehlschlagerA.C. and UnrauA.M. (1976): Sterol biosynthesis in antibiotic sensitive and resistant Candida - Arch. Biochem. Biophys. 173: 171–177.

    Google Scholar 

  54. GaleE.F. (1974): The release of potassium ions from Candida albicans in the presence of polyene antibiotics - J. Gen. Micro. 80: 451–465.

    Google Scholar 

  55. GaleE.F., AlisonM., JohnsonD.M., KerridgeD. and MilesE.A. (1978): Phenotypic resistance to amphotericin B in Candida albicans: the role of reduction - J. Gen. Microbiol. 109: 191–204.

    Google Scholar 

  56. GaleE.F., JohnsonA.M. and KerridgeD. (1977): The effects of aeration and metabolic inhibitors on resistance to amphotericin in starved cultures of Candida albicans - J. Gen. Microbiol. 99: 77–84.

    Google Scholar 

  57. GaleE.F., JohnsonA.M., KerridgeD. and KohT.Y. (1975): Factors affecting the changes in amphotericin sensitivity of Candida albicans during growth - J. Gen. Microbiol. 87: 20–36.

    Google Scholar 

  58. GaleE.F., IngramJ, KerridgeD., NotarioY. and WaymanF. (1980): Reduction of amphotericin resistance in stationary phase cultures of Candida albicans by treatment of enzymes - J. Gen. Microbiol. 117: 383–391.

    Google Scholar 

  59. GarganiG., CampisiE. and FaggiE. (1976): Fréquence et caractéristiques des souches de C. albicans résistantes à la 5-fluorocytosine - Bull. Soc. fr. Mycol. méd. 5: 95–97.

    Google Scholar 

  60. Garrique I.L., Sande M.A. and Utz J.P. (1973): Combined amphotericin B — flucytosine chemotherapy in human cryptococcosis — Abst. 13th Intersci. Conf. Antimicrob. Agents Chemother. Washington, D.C. — No. 239.

  61. GordonM.A., HolzmanR.S., SenterH., LapaE.W. and KupersmithM.J. (1976): Aspergillus oryzae meningitis- J. Am. Med. Ass. 235: 2122–2123.

    Google Scholar 

  62. GreeneW.H. and WiernikP.H. (1972): Candida endophthalmitis, successful treatment in a patient with acute leukemia - Am. J. Ophthal. 74: 1100–1102.

    Google Scholar 

  63. GrensonM. (1969): The utilization of exogenous pyrimidines and the recycling of uridine-5′-phosphate derivatives in Saccharomyces cerevisiae, as studied by means of mutants affected in pyrimidine uptake and metabolism - Eur. J. Biochem. 11: 249–260.

    Google Scholar 

  64. 64.GrillotR., SlavovR., GrayralJ.P., BuissièreJ. and Ambroise-ThomasP. (1975): Sensibilité de 250 souches de levures á la flucytosine et a l'ámphotéricin B - Bull. Soc. fr. Mycol. méd. 4:173–176.

    Google Scholar 

  65. GrinE.I., NadazdinM. and OzegovicL. (1965): Investigations of dermatophyte sensitivity to griseofulvin - Acta Derm. Venereol. 45: 283–287.

    Google Scholar 

  66. HalkinH., RavidM., ZulmanJ. and ReichertN. (1974): Cryptococcal meningitis treated with 5-fluorocytosine and amphotericin B - Israel J. Med. Sci. 10: 1048–1052.

    Google Scholar 

  67. HamiltonJ.D. and EliottD.M. (1975): Combined activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans in vitro and in vivo in mice - J. Infect. Dis. 131: 129–137.

    Google Scholar 

  68. Hamilton-MillerJ.M.T. (1972a): A comparative in vitro study of amphotericin B, clotrimazole and 5-fluorocytosine against clinically isolated yeasts -Sabouraudia 10: 276–283.

    Google Scholar 

  69. Hamilton-MillerJ.M.T. (1972b): Physiological properties of mutagen-induced variants of Candida albicans resistant to polyene antibiotics - J. Med. Microbiol. 5: 425–440.

    Google Scholar 

  70. Hamilton-MillerJ.M.T. (1972c): Sterols from polyene resistant mutants of Candida albicans - J. Gen. Microbiol. 73: 201–203.

    Google Scholar 

  71. HammondS.M. and KligerB.N. (1976): Mode of action of the polyene antibiotic candidin: binding factors in the wall of Candida albicans - Antimicrob. Agents Chemother. 9: 561–568.

    Google Scholar 

  72. HantschkD. and GoetzH. (1981): Griseofulvin resistance - Int. Dermatol. 18: 249–260.

    Google Scholar 

  73. HarderE.J. and HermanP.E. (1975): Treatment of fungal infections with flucytosine - Arch. Intern. Med. 135: 1269–1270.

    Google Scholar 

  74. HebekaE.X. and SolotorovskyM. (1962): Development of strains of Candida albicans resistant to candidin - J. Bacteriol. 84: 237–241.

    Google Scholar 

  75. HebekaE.K and SolotorovskyM. (1965): Development of resistance to polyene antibiotics in Candida albicans - J. Bacteriol. 89: 1533–1539.

    Google Scholar 

  76. HejzlarM. and VymolaF. (1970): Comparative study of pimaricin and fungicidin activity in vitro - J. Hyg. Epidem. Microbiol. Immun. 14: 211–213.

    Google Scholar 

  77. HitchcockC.A., Barrett-BeeK.J. and RussellN.J. (1986): The lipid composition of azole-sensitive and azole-resistant strains of Candida albicans - J. Gen. Microbiol. 132: 2421–2431.

    Google Scholar 

  78. HitchcockC.A., Barrett-BeeK.J. and RussellN.J. (1987a): Inhibition of 14 α — sterol demethylase activity in Candida albicans Darlington does not correlate with resistance to azole - J. Med. Vet. Mycol. 25: 329–333.

    Google Scholar 

  79. HitchcockC.A., Barrett-BeeK.J. and RussellN.J. (1987b): The lipid composition and permeability to azole of an azole- and polyene-resistant mutant of Candida albicans - J. Med. Vet. Mycol. 25: 29–37.

    Google Scholar 

  80. HoeprichP.D., IngrahamJ.L., KlekerE. and WinshipM.J. (1974): Development of resistance to 5-fluorocytosine in Candida paropsilosis during therapy- J. Infect. Dis. 130: 112–118.

    Google Scholar 

  81. HolbrookW.P. and KippaxR. (1979): Sensitivity of Candida albicans from patients with chronic candidiasis - Postgrad. Med. J. 55: 692–694.

    Google Scholar 

  82. HoltR.J. (1974): Recent developments in antimycotic chemotherapy - Infection 2: 95–107.

    Google Scholar 

  83. HoltR.J. and AzmiA. (1978): Miconazole-resistant Candida - Lancet i: 50–51.

    Google Scholar 

  84. HoltR.J. and NewmanR.L. (1972a): Laboratory assessment of the antimycotic drug clotrimazole - J. Clin. Path. 25: 1089–1097.

    Google Scholar 

  85. HoltR.J. and NewmanR.L. (1972b): Urinary candidiasis after renal transplantation - Br. Med. J. 2: 714–715.

    Google Scholar 

  86. HoltR.J. and NewmanR.L. (1972c): The treatment of urinary candidosis with the oral and antifungal drugs 5-fluorocytosine and clotrimazole - Devl. Med. Child Neurol. 14 Suppl. 27: 70–78.

    Google Scholar 

  87. HorneM.J., TaylorR.F., WilliamsR. and ZylstraW. (1975): Candida endophthalmitis - Med. J. Aust. 62: 170–172.

    Google Scholar 

  88. HorsburghC.R. and KirkpatrikC.H. (1983): Longterm therapy of chronic mucocutaneous candidosis with ketoconazole: experience with twenty-one patients - Am. J. Med. 74: 23–29.

    Google Scholar 

  89. HorsburghC.R., KirkpatrikC.H. and TeutschC.B. (1982): Ketoconazole and the liver - Lancet i: 23–29.

    Google Scholar 

  90. HsuK.S. (1963): The genetic basis of actidione resistance in Neurospora - J. Gen. Microbiol. 32: 341–347.

    Google Scholar 

  91. HsuChenC-C. and FeingoldD.S. (1974): Two types of resistance to polyene antibiotics in Candida albicans- Nature 251: 656–659.

    Google Scholar 

  92. HughesC.E., BennetR.L., TunaI.C. and BeggsW.H. (1988): Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and —resistant Candida albicans - Antimicrob. Agents Chemother. 32: 209–212.

    Google Scholar 

  93. HutletJ (1976): Evaluation of 2 methods of in vitro susceptibility testing of Candida albicans against 5-fluorocytosine- Can. J. Med. Technol. 38: 169–172.

    Google Scholar 

  94. IbrahimM.A.K. and CoddingtonA. (1976): Genetic studies on cycloheximide-resistant strains of Schizosaccharomyces pombe - Heredity 37: 179–191.

    Google Scholar 

  95. IwataK., YamashitaT., OhsumiM., BabaM., NaitoN., TakiA. and YamadaN. (1990): Comparative morphological and biological studies on the itraconazole- and ketoconazole-resistant mutans of Cryptococcus neoformans - J. Med. Vet. Mycol. 28: 77–90.

    Google Scholar 

  96. IwataK., YamashitaT. and UeharaH. (1989): In vitro and in vivo activity of piritetrate (M-732), a new antidermatophytic thiocarbamate - Antimicrob. Agents Chemother. 33: 2118–2125.

    Google Scholar 

  97. IwataK., YamashitaT., UeharaH. and NozawaY. (1990): In vitro thiocarbamate resistance of Trichophyton mentagrophytes - Chemotherapy (Tokyo) 38: 437–443.

    Google Scholar 

  98. JohnsonE.M., RichardsonM.D. and WarnokD.W. (1984): In vitro resistance to imidazole antifungals in Candida albicans - J. Antimicrob. Chemother. 13: 547–588.

    Google Scholar 

  99. JundR. and LacrouteF. (1970): Genetic and physiological aspects of resistance to 5-fluoropyrimidines in Saccharomyces cerevisiae - J. Bacteriol. 102: 607–615.

    Google Scholar 

  100. JundR. and LacrouteF. (1974): Génétique et physiologie de la résistance aux 5-fluoropyrimidines chez Saccharomyces cerevisiae - Bull. Soc. fr. Mycol. Méd. 3: 5–8.

    Google Scholar 

  101. KamalamA., YesudianP. and ThambiahA.S. (1977): An unusual presentation of Trichophyton violaceum infection - Br. J. Dermatol. 96: 205–209.

    Google Scholar 

  102. KauffmanC.A. and TanJ.S. (1974): Torulopsis glabrata renal infection - Am. J. Med. 57: 217–224.

    Google Scholar 

  103. KitaharaM., SethV.K., MedoffG. and KobayashiG.S. (1976): Activity of amphotericin B, 5-fluorocytosine and rifampicin against six clinical isolates of Aspergillus - Antimicrob. Agents Chemother. 9: 915–919.

    Google Scholar 

  104. KobayashiG.S., CheungS.C., SchlessingerD. and MedoffG. (1974): Effects of rifamycin derivatives, alone and in combination with amphotericin B, against Histoplasma capsulatum - Antimicrob. Agents Chemother. 5: 16–18.

    Google Scholar 

  105. KobayashiG.S., MedoffG., SchlessingerD., KwanC.N. and MusserW.E. (1972): Amphotericin B potentiation of rifampicin as an antifungal agent against the yeast phase of Histoplasma capsulatum -Science 177: 709–710.

    Google Scholar 

  106. KostelnikF.V. and FremountH.N. (1976): Mycotic tubo-ovarian abscess associated with intrauterine device - Am. J. Obstet, Gynec. 125: 272–274.

    Google Scholar 

  107. KostialaA.A.I. and KostialaI. (1984): Susceptibility of fungi in mouthrise specimens from patients with haematological malignancies - J. Med. Microbiol. 18: 249–254.

    Google Scholar 

  108. KwanC.N., MedoffG., KobayashiG.S., SchlessingerD. and RaskasH.J. (1972): Potentiation of the antifungal effects of antibiotics by amphotericin B -Antimicrob. Agents Chemother. 2: 61–65.

    Google Scholar 

  109. LampenJ.O., MorganE.R. and SlocumA. (1957): Effect of nystatin on the utilization of substrates by yeast and other fungi - J. Bacteriol. 74: 297–302.

    Google Scholar 

  110. LauerB.A., RellerL.B. and SchroterG.P.J. (l978): Susceptibility of Aspergillus to 5-fluorocytosine and amphotericin B alone and in combination - J. Antimicrob. Chemother. 4: 375–380.

    Google Scholar 

  111. LenhartK (1970): Griseofulvin-resistant mutants in dermatophytes: II. Physiological and genetic studies- Mykosen 13: 139–144.

    Google Scholar 

  112. Littman M.L., Pisano M.A. and Lancaster R.M. (1958): Induced resistance of Candida species to nystatin and amphotericin B - Antibiot. Ann., 1957–1958, 981–987.

  113. LonesG.W. and PeacockC.L. (1959): Alterations in Candida albicans during growth in the presence of amphotericin B - Antibiot. Chemother. 9: 535–540.

    Google Scholar 

  114. LopesC.F., ResendeM.A., AlvarengaR.J., MoreiraY.K. and FerreiraI. (1978): 5-Fluorocytosine in the treatment of chromomycosis, in current chemotherapy, Proc. 10th Int. Congr., chemother., Zurich. In: Siegenthaler W. and Lilthy R. eds. American Society of Microbiology - Ann. Arbor. Vol. 1: pp. 219–220.

    Google Scholar 

  115. MarksM.I., SteerP. and EickoffT.C. (1971): In vitro sensitivity of Torulopsis glabrata to amphotericin B, 5-fluorocytosine and clotrimazole - Appl. Microbiol. 22: 93–96.

    Google Scholar 

  116. MedoffG., ComfortM. and KobayashiG.S. (1971): Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms - Proc. Soc. Exp. Biol. Med. 138: 571–574.

    Google Scholar 

  117. MedoffG., KobayashiG.S., KwanC.N., SchlessingerD. and VenkovP. (1972): Potentiation of rifampin and 5-fluorocytosine as antifungal antibiotics by amphotericin B - Proc. Natn. Acad. Sci. USA 69: 196–199.

    Google Scholar 

  118. MeyersB.R., LiebermanT.W. and FerryA.P. (1973): Candida endophthalmitis complicating candidemia- Ann. Intern. Med. 79: 647–653.

    Google Scholar 

  119. MichaelidesP., RosenthalS.A., SulzbergerM.B. and WittenY.R. (1961): Trichophyton tonsurans infection resistant to griseofulvin: a case demonstrating clinical and in vitro resistance - Arch. Dermatol. 83: 988–990.

    Google Scholar 

  120. Michalska-TrenknerE. (1970): Induced resistance of C. albicans strains to sodium salt of N-succinyl perimycin - Chemotherapy (Basel) 15: 19–25.

    Google Scholar 

  121. MolzahnS. and WoodsR.A. (1972): Polyene resistance and the isolation of sterol mutants in Saccharomyces cerevisiae - J. Gen. Microbiol. 72: 339–348.

    Google Scholar 

  122. MontgomerieJ.Z., EdwardsJ.E.Jr. and GuzeL.B. (1975): Synergism of amphotericin B and 5-fluorocytosine for Candida species - J. Infect. Dis. 132: 82–86.

    Google Scholar 

  123. MontplaisirS., DrouhetE. and Mercier-SoucyL. (1975): Sensitivity and resistance of pathogenic yeasts to 5-fluorocytosine. II. Mechanisms of resistance to 5-fluorocytosine and 5-fluorouracil -Ann. Microbiol. (Inst. Past.) 126B: 41–49.

    Google Scholar 

  124. NeuhäsuserA., KlingmüllerE. and KaudewitzF. (1970): Selektion Actidion-resistenter Mutanten bei Neurospora crassa - Molec. Gen. Genet. 106: 180–194.

    Google Scholar 

  125. NormanA.W., SpielvogelA.M. and WongR.C. (1976): Polyene antibiotic-sterol interaction -Adv. Lipid Res. 14: 127–170.

    Google Scholar 

  126. NormarkS. and SchönebeckJ. (1972): In vitro and in vivo 5-fluorocytosine resistance in Candida albicans and Torulopsis glabrata - Antimicrob. Agents Chemother. 2: 114–121.

    Google Scholar 

  127. NorthJ. (1982): A dominance modifier for cycloheximide resistance in Coprinus cinereus - J. Gen. Microbiol. 128: 2747–2753.

    Google Scholar 

  128. NotarioV., GaleE.F., KerridgeD. and WaymanF. (1982): Phenotypic resistance to amphotericin B in Candida albicans: relationship to glucan metabolism - J. Gen. Microbiol. 128: 761–777.

    Google Scholar 

  129. PankeyG.A., LockwoodW.R. and MontalvoJ.M. (1970): 5-Fluorocytosine: a replacement for amphotericin B in the treatment of Candida and Cryptococcus neoformans infections? - J. La St. Med. Soc. 122: 365–369.

    Google Scholar 

  130. PappagianisD., CollinsM.S., HectorR. and RemingtonJ. (1979): Development of resistance to amphotericin B in Candida lusitaniae infecting a human - Antimicrob. Agents Chemother. 16: 123–126.

    Google Scholar 

  131. PatelP.V. and JohnstonJ.R. (1968): Dominant mutation for nystatin resistance in yeast - Appl. Microbiol. 16: 164–165.

    Google Scholar 

  132. PerrotM.O., GrillotR. and Ambroise-ThomasP. (1977): Répartition dans l'organisme et sensibilité à la 5-fluorocytosine des 2 sérotypes de Candida albicans, étude de 680 souches - Bull. Soc. fr. Mycol. Méd. 6: 305–309.

    Google Scholar 

  133. PerryH.O. and UlrichJ.A. (1955): Laboratory studies on endomycin, with special reference to its antifungal effect against Candida albicans - J. Invest. Dermatol. 24: 623–631.

    Google Scholar 

  134. PerssonM., WinbladB., ÅnsênS. and SchönebeckJ. (1978): Pathogenicity in mice of strains of Candida albicans with different in vitro sensitivity to 5-fluorocytosine- Scand. J. Infect. Dis. 10: 91–92.

    Google Scholar 

  135. PlempelM. and BartmannK. (1972): Experimental studies on the antimycotic action of clotrimazole (Canesten) in vitro and after local application in vivo- Drugs Germ. 15: 103–120.

    Google Scholar 

  136. PolakA. (1974): Détermination du synergisme entre la 5-fluorocytosine et l'amphotéricin B au moyen de différents modèles in vitro et in vivo - Bull. Soc. fr. Mycol. Méd. 3: 175–178.

    Google Scholar 

  137. PolakA. (1978): Synergism between 5-fluorocytosine and polyene antibiotics - Pathol. Microbiol. 42: 423–425.

    Google Scholar 

  138. PolakA. and ScholerH.J. (1975): Mode of action of 5-fluorocytosine and mechanisms of resistance -Chemotherapy (Basel) 21: 113–130.

    Google Scholar 

  139. PolakA. and ScholerH.J. (1976): Combination of amphotericin B and 5-fluorocytosine - In: Williams J.D. and Geddes A.M. eds. Chemotherapy, Proc. 9th International Congress of Chemotherapy, London, 1975, Plenum Press, New York, Vol. 6, pp. 137–142.

    Google Scholar 

  140. PortilloF. and GancedoC. (1985): Mitochondrial resistance to miconazole in Saccharomyces cerevisiae- Molec. Gen. Genet. 199: 495–499.

    Google Scholar 

  141. RabinovichS., ShawB.D., BryantT. and DontaS.T. (1974): Effect of 5-fluorocytosine and amphotericin B on Candida albicans infection in mice - J. Infect. Dis. 130: 28–31.

    Google Scholar 

  142. RecordC.O., SkinnerJ.M., SleightP. and SpellerD.C.E. (1971): Candida endocarditis treated with 5-fluorocytosine - Br. Med. J. i: 262–264.

    Google Scholar 

  143. RobinsonM.F., Forgan-SmithW.R. and CraswellP.W. (1975): Candida thyroiditis — treated with 5-fluorocytosine- Aust. N.Z. J. Med. 5: 472–474.

    Google Scholar 

  144. RupprechtL., JanzenR. and VossH.V. (1974): Candidiasis bei immunsuppressiver Therapie in Kindesalter] - Monatsschr. Kinderheilkd. 122: 653–654.

    Google Scholar 

  145. RyleyJ.F., WilsonR.G. and Barret-BeeK.J. (1984): Azole resistance in Candida albicans - Sabouraudia 22: 53–63.

    Google Scholar 

  146. SafeL.M., SafeS.H., SubdenR.E. and MorrisD.C. (1977): Sterol content and polyene antibiotic resistance in isolates of Candida krusei, Candida parakrusei, and Candida tropicalis - Can. J. Microbiol. 23: 398–401.

    Google Scholar 

  147. SalkinI.F. and HurdN. (1972): Quantitative evaluation of the antifungal properties of cycloheximide - Antimicrob. Agents Chemother. 1: 177–184.

    Google Scholar 

  148. ScandellaD., RooneyR. and KatzE.R. (1980): Genetic, biochemical, and developmental studies of nystatin resistant mutant in Dictyostelium discoideum - Molec. Gen. Genet. 180: 67–75.

    Google Scholar 

  149. ScholerH.J. (1974): Experimental chemotherapy of aspergillosis. In: De Haller R. and Suter E. eds. Aspergillosis and Farmer's Lung in Man and Animal. Huber, Bern, pp. 136–147.

    Google Scholar 

  150. ScholerH.J. (1976): Grundlagen und Ergebnisse der antimykotischen Chemotherapie mit 5-Fluorocytosine- Chemotherapy (Basel) 22: 103–146.

    Google Scholar 

  151. ScholerH.J. (1980): Flucytosine. In: Speller D.C.E. ed. Antifungal Chemotherapy. John Wiley & Sons, New York, N.Y. pp. 35–106.

    Google Scholar 

  152. SchönebeckJ. and ÅnsêhnS. (1973): 5-Fluorocytosine resistance in Candida spp. and Torulopsis glabrata - Sabouraudia 11: 10–20.

    Google Scholar 

  153. SchröterG.P., TempleD.R., HusbergB.S., WeilR. and StarzlT.E. (1976): Cryptococcosis after renal transplantation; report of ten cases - Surgery 79: 268–277.

    Google Scholar 

  154. SegalE., RomanoA., EylanE. and SteinR. (1975): Experimental and clinical studies of 5-fluorocytosine activity in Candida ocular infections. I. In vitro activity of 5-fluorocytosine on Candida sp.- Chemotherapy (Basel) 21: 358–366.

    Google Scholar 

  155. ShadomyS. (1970): Further in vitro studies with 5-fluorocytosine- Infect. Immun. 2: 484–488.

    Google Scholar 

  156. ShadomyS., KirchhoffC.B. and IngroffA.E. (1973): In vitro activity of 5-fluorocytosine against Candida and Torulopsis species - Antimicrob. Agents Chemother. 3: 9–14.

    Google Scholar 

  157. ShadomyS., ShadomyH.J., McCayJ.A. and UtzJ.P. (1969): In vitro susceptibility studies with Cryptococcus neoformans and amphotericin B, hamycin and 5-fluorocytosine - Antimicrob. Agents Chemother. - 1968, American Society of Microbiology, Ann Arbor, pp. 452–460.

    Google Scholar 

  158. ShadomyS., WagnerG., Espinel-IngroffA. and DaviesB.A. (1975): In vitro studies with combinations of 5-fluorocytosine and arnphotericin B - Antimicrob. Agents Chemother. 8: 117–121.

    Google Scholar 

  159. SheldonG.M. and AlexanderR.L. (1974): Candida endophthalmitis - Can. J. Ophthalmol. 9: 146–149.

    Google Scholar 

  160. SmithK.J., WarnockD.W., KennedyC.T.C., JohnsonE.M., HopwoodV., VanCutsemJ, and Vanden BosscheH. (1986): Azole resistance in Candida albicans - J. Med. Vet. Mycol. 24: 133–144.

    Google Scholar 

  161. SnowR.M. and DismukesW.E. (1975): Cryptococcal meningitis - Arch. Intern. Med. 135: 1155–1157.

    Google Scholar 

  162. Sorensen L.J., McNall E.G. and Sternberg T.H. (1959): The development of strains of Candida albicans and Coccidioides immitis, which are resistant to amphotericin B — Antibiot. Ann. 1958–1959. pp. 920–923.

  163. SpellerD.C.E. (1974): Torulopsis glabrata urinary tract infection treated with 5-fluorocytosine - J. Clin. Path. 27: 50–52.

    Google Scholar 

  164. SpellerD.C.E. and DaviesM.G. (1973): Sensitivity of yeasts to 5-fluorocytosine - J. Med. Microbiol. 6: 315–321.

    Google Scholar 

  165. SteerP., MarksM.J., KliteP.D. and EickhoffT.C. (1972): 5-fluorocytosine, an oral antifungal compound - Ann. Intern. Med. 76: 15–22.

    Google Scholar 

  166. StillerR.L., BennetJ.E., ScholerH.J., WallM., PolakA. and StevensD.A. (1982): Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States -Antimicrob. Agents Chemother. 22: 482–487.

    Google Scholar 

  167. StoneR.D., IrvineA.R. and O'ConnerG.R. (1975): Candida endophthalmitis: report of an unusual case with isolation of the etiologic agent by vitreous biopsy - Ann. Ophthalmol. 7: 757–762.

    Google Scholar 

  168. Stout H.A. and Pagano J.F. (1956): Resistance studies with nystatin – Antibiot. Ann. 1955–1956, pp. 704–710.

  169. SugarmanB. and PesantiE. (1980): Treatment failure secondary to in vivo development of drug resistance by microorganisms - Rev. Infect. Dis. 2: 153–168.

    Google Scholar 

  170. TavitianA., RaufmanJ.-P., RosenthalL.E, WeberJ., WebberC.A. and DincsoyH.P. (1986): Ketoconazole-resistant Candida esophagitis in patients with acquied immunodeficiency syndrome -Gastroenterol. 90: 443–445.

    Google Scholar 

  171. TitsworthE. and GrunbergE. (1973): Chemotherapeutic activity of 5-fluorocytosine and amphotericin B against Candida albicans in mice -Antimicrob. Agents Chemother. 4: 306–308.

    Google Scholar 

  172. TuylJ.M. van (1975): Genetic aspects of acquired resistance to benomyl and thiabendazole in a number of fungi - Mel. Fac. Landbouww. Rijksuniv. Gent. 40: 691–697.

    Google Scholar 

  173. UrabeH., SuenagaY., YasudaM. and KodaH. (1977): Treatment of cutaneou candidiasis and chromomycosis with 5-fluorocytosine In: Iwata K. ed. Recent Advances in Medical and Veterinary Mycology. Proc. 6th International Congress of ISHAM, Tokyo, 1975, University of Tokyo Press, Tokyo, pp. 97–106.

    Google Scholar 

  174. UtzJ.P., GarriquesI.L., SandeM.A., WarnerJ.F., McGeheeR.F. and ShadomyS. (1975): Combined flucytosine-amphotericin B treatment of cryptococcal infections - J. Infect. Dis. 132: 368–373.

    Google Scholar 

  175. UtzJ.P. and ShadomyS. (1977): Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testing - J. Infect. Dis. 135: 970–974.

    Google Scholar 

  176. VaughanS. (1977): The sensitivity of C. albicans to 5-fluorocytosine - N.Z.J. Med. Lab. Technol. 31:4–5.

    Google Scholar 

  177. WagnerG., ShadomyS., PaxtonL.D. and Espinel-IngroffA. (1975): New method for susceptibility testing with antifungal agents - Antimicrob. Agents Chemother. 8: 107–109.

    Google Scholar 

  178. WaitzJ.A., MossE.C. and WeinsteinM.J. (1971): Chemotherapeutic evaluation of clotrimazole. -Appl. Microbiol. 22: 891–894.

    Google Scholar 

  179. WarnocD.W., JohnsonG.M. and RichardsonM.D. (1983): Modified response to ketoconazole of Candida albicans from a treatment failure -Lancet i: 642–643.

    Google Scholar 

  180. WatsonP.E., RoseM.E. and KellyS.L. (1988): Isolation and analysis of ketoconazole resistant mutants of Saccharomyces cerevisiae - J. Med. Vet. Mycol. 26: 153–162.

    Google Scholar 

  181. WhelanW.L., BenekeE.S., RogersA.L. and SoilD.R. (1981): Segregation of 5-fluorocytosine-resistant variants by Candida albicans - Antimicrob. Agents Chemother. 19: 1078–1081.

    Google Scholar 

  182. WhelanW.L. and MageeP.T. (1981): Natural heterozygosity in Candida albicans - J. Bacteriol. 145: 896–903.

    Google Scholar 

  183. WhelanW.L., PatridgeR.M. and MageeP.T. (1980): Heterozygosity and segregation in Candida albicans- Molec. Gen. Genet. 180: 107–113.

    Google Scholar 

  184. WhiffenA.J. (1948): The production, assay and antibiotic activity of actidione, an antibiotic from Streptomyces griseus - J. Bacteriol. 56: 283–291.

    Google Scholar 

  185. WhitingD.A. (1967): Treatment of chromoblastomycosis with high local concentrations of amphotericin B - Br. J. Dermatol. 79: 345–351.

    Google Scholar 

  186. WilkieD. and LeeB.K. (1965): Genetic analysis of actidione resistance in Saccharomyces cerevisiae -Genet. Res. Camb. 6: 130–138.

    Google Scholar 

  187. WoodsR.A. (1971): Nystatin-resistant mutants of yeast; alterations in sterol content - J. Bacteriol. 108: 69–73.

    Google Scholar 

  188. WoodsR.A., BardM., JacksonI.E. and DrutzD.J. (1974): Resistance to polyene antibiotics and a correlated sterol changes in two isolates of Candida tropicalis from a patient with an amphotericin B-resistant funguria - J. Infect. Dis. 129: 53–58.

    Google Scholar 

  189. YamamotoM. (1980): Genetic analysis of resistant mutants to antimitotic benzimidazole compounds in Schizosaccharomyces pombe - Molec. Gen. Genet. 180: 231–234.

    Google Scholar 

  190. YangcoB.G., TeStrakeD. and OkaforJ. (1984): Phialophora richardsiae isolated from infected human bone - Mycopathol. 86: 103–111.

    Google Scholar 

  191. YoungC.N. (1972): Sensitivity patterns to griseofulvin of Trichophyton rubrum and other ringworm fungi - Trans a. Rep. St. John's Hosp. Derm. Soc. 58: 226–234.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Bacteriology - Faculty of Medicine, University of Tokyo, 7-3-1 Hongo Bunkyo-ku, 113, Tokyo, Japan

    K. Iwata

Authors
  1. K. Iwata
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iwata, K. Drug resistance in human pathogenic fungi. Eur J Epidemiol 8, 407–421 (1992). https://doi.org/10.1007/BF00158576

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00158576

Key words

Search

Navigation